chr3-167522363-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001366157.1(WDR49):c.2726C>T(p.Thr909Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,452,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001366157.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR49 | NM_001366157.1 | c.2726C>T | p.Thr909Ile | missense_variant | Exon 16 of 19 | ENST00000682715.1 | NP_001353086.1 | |
WDR49 | NM_001348951.2 | c.2693C>T | p.Thr898Ile | missense_variant | Exon 16 of 19 | NP_001335880.1 | ||
WDR49 | NM_001348952.2 | c.2693C>T | p.Thr898Ile | missense_variant | Exon 16 of 19 | NP_001335881.1 | ||
WDR49 | NM_001366158.1 | c.1670C>T | p.Thr557Ile | missense_variant | Exon 13 of 16 | NP_001353087.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR49 | ENST00000682715.1 | c.2726C>T | p.Thr909Ile | missense_variant | Exon 16 of 19 | NM_001366157.1 | ENSP00000507497.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1452894Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 722584
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.